NHC National Healthcare Corp

$202.70 +5.61%

Healthcare · Services-Skilled Nursing Care Facilities

National Healthcare Corp (NHC) is a healthcare company in the Services-Skilled Nursing Care Facilities industry, with a market capitalization of $3.2 billion. Shares last traded at $202.70, near their 52-week high. Over the past year the stock is up 98.5%. NHC trades at a price-to-earnings ratio of 26.38, above the Healthcare median of 25.98. Net profit margin is 7.9%, above the peer median of 0.0%. Revenue grew 16.1% year over year. The shares yield 1.9% in dividends.

Market Cap

$3.2B

Shares Out

15.6M

EPS (TTM)

$14.03

P/E Ratio

14.45

P/S Ratio

2.09

P/B Ratio

2.90

Dividend / Share

$3.81

Dividend Yield

1.88%

52-Week High

$205.21

52-Week Low

$93.42

Volume

8,909

Avg Vol (3m)

4,870.397

Performance

+3.90%

+3.33%

+28.43%

+45.40%

YTD

+55.33%

+98.53%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

64.40

SMA (50)

$182.58

SMA (200)

$149.77

Price vs SMA50

+11.02%

Price vs SMA200

+35.34%

ATR (14)

$7.12

Financials

Revenue

$1.5B

Net Income

$120M

Gross Margin

—

Operating Margin

8.5%

Net Margin

7.9%

Return on Equity

11.0%

Return on Assets

7.9%

Current Ratio

1.86

Debt / Equity

0.00

Revenue Growth (YoY)

+16.1%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$2.27	2026-05-07
FY 2025	$7.67	2026-02-26
Q3 2025	$6.10	2025-11-06
Q2 2025	$3.59	2025-08-07
Q1 2026	$2.07	2026-05-07
FY 2025	$6.53	2026-02-26

Full earnings history →

Healthcare peers

NHC vs 14 sector peers (Healthcare), by market cap.

P/E vs peers

26.38 / 25.98 med

+2% premium

P/S vs peers

2.09 / 2.59 med

-20% discount

Net margin vs peers

7.9% / 0.0% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
LIN	Linde	$236.9B	34.34	6.97	20.3%	-0.75%
AMGN	Amgen	$182.1B	23.62	4.96	21.0%	-1.27%
TMO	Thermo Fisher Scientific	$172.7B	25.70	3.88	15.1%	+0.67%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
GILD	Gilead Sciences	$153.5B	18.04	5.21	28.9%	-1.46%
ISRG	Intuitive Surgical	$144.0B	50.41	14.30	28.4%	+1.06%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
DHR	Danaher Corporation	$125.4B	34.70	5.10	14.7%	-0.38%
SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.